logo 600X600.png
Global Dementia Drugs Market to Surpass US$ 39,663.6 Million by 2030, Says Coherent Market Insights (CMI)
July 26, 2022 08:40 ET | CMI
Seattle, July 26, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global dementia drugs market is estimated to be valued at US$ 20,677.0 million in 2022 and is expected to...
Future Market Insights.png
Alzheimer’s Therapeutics Market Is Set to Expand at a CAGR Of 9.3% To reach US$ 6.8 Bn By The Year 2032 : FMI DUBAI, United Arab Emirates, April 15, 2022 (GLOBE NEWSWIRE) -- Alzheimer’s Therapeutics is the most common reason for progressive dementia in the elderly population. There has been an exponential...
Global Alzheimer’s Therapeutics Market is Expected to Reach USD 8.19 Billion By 2026 : Fior Markets
July 09, 2019 07:57 ET | Fior Markets
New Jersey, NJ, July 09, 2019 (GLOBE NEWSWIRE) -- Fior Markets launched a study titled "Alzheimer’s Therapeutics Market by Drug Type (Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor...
RND logo.PNG
Alzheimer’s Therapeutics Market to Reach USD 12.43 Billion By 2026 | Reports And Data
May 02, 2019 12:00 ET | Reports And Data
Rising incidence of investment in biomarkers for drug development is the major factor influencing market growth. Market Size – USD 18.23 billion in 2018, Market Growth - CAGR of 4.6%, Market Trends...